StockTipsArenaBeta

BUY Cohance Lifesciences Limited — Rakesh Bansal

BUYCohance Lifesciences Limited
Cohance Lifesciences share price target & all analyst calls

byRakesh BansalHorizon: NA (inferred 1–3 months)29 Oct 2026via CNBC Awaaz.

Entry₹486.8Inferred
Target₹535
Total upside +9.90%
Stop loss₹465-4.48% risk
CMP₹478.65Just now
Active-1.67%+11.77%upside left 3 mo left
Follow Rakesh Bansal for new calls(31% target hit, 26 closed calls)Get alertsWatch COHANCE for new buy/sell callsGet alertsSee 1 other Short-term call on COHANCESee 65 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 1:56 pm IST
3 supporting3 neutral1 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·29 Oct · today

5 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·29 Oct · today

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·18 Aug · 2mo ago

Neutral / worth noting (3)

Q2 FY27 results scheduled — board meets 06 Nov 2026

BSE · Board Meeting·In 8 days

(opens in new tab)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company.

BSE · Company Update·9 Oct · 3w ago

(opens in new tab)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company effective October 12, 2026.

NSE · Appointment·9 Oct · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·6 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Cohance Lifesciences

All analyst calls on Cohance Lifesciences

More from Rakesh Bansal

Every call and its outcome